What Abu Dhabi Biobank does

Abu Dhabi Biobank is a strategically-backed biobanking and biomedical research infrastructure initiative operated by G42 Laboratory LLC (an M42 affiliate) in partnership with the Department of Health Abu Dhabi. Headquartered in a net-zero facility in Masdar City with capacity for 100,000+ cord blood samples and 5,000,000+ biological specimens, the company operates five core biobanking products: region's largest hybrid Cord Blood Bank (combining public and private storage), Pan Human Biobank (longitudinal samples linked to clinical and genomic data for 200+ nationalities), Middle East's first Tumor Bank, region's first specialized Eye Bank, and Ovarian/Testicular Cryopreservation for fertility preservation. Technology is anchored on robotic automation for sample processing and storage, advanced cryogenic systems supporting 30-year viability, and a Unique Identification Number (UIN) system for traceability, with ISO 20387, AABB, ISO 27001, and Sharia compliance certifications.

The business model is multi-streamed and structurally subsidized. Direct-to-consumer revenue is generated through private cord blood banking packages (Bronze AED 7,500, Silver AED 10,000, Gold AED 12,500 for 30-year storage), priced at approximately half the prevailing UAE market rates and distributed via a 200+ partner hospital network and digital channels (website, 800 213 phone, WhatsApp). B2B revenue streams include subscription and project-based contracts with pharmaceutical and biotech companies for biospecimens, biomarker discovery, multi-omics, clinical trial support, regulatory and ethical compliance, and global cold-chain logistics. Public cord blood banking is free to families and is funded through government partnership (DoH) as part of national health infrastructure. Customer segments span expectant families (primary), pharmaceutical and biotech companies, academic and research institutions, government and public health organizations, and healthcare providers.

The company is positioned as a translational research hub, integrating biological samples with the Emirati Genome Programme (850,000+ genomes), Malaffi EMR, and longitudinal health records. Recent strategic moves include partnerships with AstraZeneca (precision medicine), BioTwin (AI Virtual Human Twin for multi-cancer screening), Human Life CORD Japan (UC-MSC therapies), and Bascom Palmer Eye Institute (Eye Bank), signaling an evolution from a pure biobanking service toward a vertically integrated health data and cell therapy platform. The company is private, government-backed, and operates under DoH regulatory oversight with no external funding rounds disclosed.

Name

Abu Dhabi Biobank

Legal name

Abu Dhabi Biobank (operated by G42 Laboratory LLC)

Website

https://abudhabibiobank.ae

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

11–50 employees

Short description

Abu Dhabi Biobank is a government-backed biobanking initiative in Masdar City, Abu Dhabi, operating cord blood, pan-human, tumor, eye, and fertility cryopreservation services for expectant families, pharma, biotech, and research institutions across the UAE.

Ownership category

akta.pro rank

Product category

Biobanking Services

NAICS

Blood and Organ Banks (621991), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Biological Products, (No Disgnostic Substances) (2836), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)

akta.pro secondary industries

Biobank & Biospecimen Management LIMS (HLACAMAG), Sample / Biorepository & Biobank Informatics (Chain-of-Custody) (HLAGAJAH), Cryopreservation, Biobanking & Cell Banking (Cord/Adipose/MSC) (HLAMANAJ), Transfusion Medicine & Immunohematology (Blood Bank) (HLAFAMAG)

Keywords

• Biobanking services
• Cord blood banking
• Biospecimen storage
• Stem cell preservation
• Clinical research support

Headquarters

HQ city

Abu Dhabi

HQ country

United Arab Emirates

HQ region

Middle East

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Infrastructure, Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Private Cord Blood Banking Services: One-time fees for cord blood collection, processing, testing, and 30-year storage. Three pricing tiers (Bronze AED 7,500, Silver AED 10,000, Gold AED 12,500) with renewal rebates upon completion of initial storage period. Revenue is recognized upfront for the storage service period with potential add-on services.
2. Biobanking Services for Pharma and Biotech: Provides high-quality biospecimens, data integration, and translational research support to pharmaceutical companies. Services include patient stratification, pre-screening, cohort design, biomarker discovery, and clinical trial support. Revenue generated through project-based contracts and subscription access to de-identified databases.
3. Research and Development Services: Biomarker discovery and validation pipelines, molecular assays, sequencing, genotyping, histopathology, digital pathology, organoid and iPSC development. Revenue generated through consultancy engagements, advisory support, and research project collaborations.
4. Public Cord Blood Banking: Free donation service for public banking. Revenue not generated directly from families; supported through government partnerships and DoH funding as part of national health infrastructure.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

Abu Dhabi Biobank collects, processes, and cryopreserves biological samples — including cord blood, tumor tissue, reproductive tissue, and longitudinal pan-human biospecimens — for up to 30 years. It offers both private (paid family storage) and public (free donation) cord blood banking, plus B2B biospecimen and translational research services to pharmaceutical, biotech, and academic clients. The biobank links samples with genomic, clinical, and lifestyle data to enable precision medicine, biomarker discovery, and clinical trial support.

Product overview

Abu Dhabi Biobank is a purpose-built health ecosystem operated by M42 in partnership with the Department of Health Abu Dhabi. The platform consists of five core biobanking products: Cord Blood Bank (region's largest hybrid cord blood bank for stem cell storage), Pan Human Biobank (longitudinal samples linked to health data for 200+ nationalities), Tumour Bank (clinically annotated tissue for cancer research), Eye Bank (region's first corneal tissue bank), and Ovarian/Testicular Cryopreservation (fertility preservation). These are supported by six service modules: Sample Collection/Processing/Storage, Global Logistics/Distribution, R&D Services, Data/Bioinformatics Support, Clinical Trial/Translational Support, and Regulatory/Ethical/Compliance Services. The offering includes both Public Banking (donation for research) and Private Banking (family-exclusive storage in three pricing tiers).

Differentiator

Problem solved

Functional benefit

Products and services

• Cord Blood Bank The region's largest hybrid cord blood bank that collects, processes, and stores cord blood containing hematopoietic stem cells for transplants and regenerative therapies for over 80 conditions including thalassemia, sickle cell anemia, and leukemia.
• Pan Human Biobank Longitudinal biological samples integrated with health, lifestyle, and environmental data for a diverse population representing 200+ nationalities, enabling earlier detection, accurate diagnosis, and personalized treatments.
• Tumour Bank Clinically annotated tissue samples linked with real-world clinical outcomes, supporting development and evaluation of more accurate diagnostics and targeted therapeutic strategies for cancer researchers.
• Eye Bank The region's first specialized eye bank enabling recovery, processing, preservation, and distribution of corneal tissue for sight-restoring transplants, reducing reliance on imported donor tissue.
• Ovarian and Testicular Cryopreservation Fertility preservation service supporting patients facing cancer treatment or reproductive health conditions, safeguarding reproductive potential through tissue cryopreservation.
• Private Cord Blood Banking Exclusive storage of cord blood stem cells for family use, cryopreserved for up to 30 years with Bronze (AED 7,500), Silver (AED 10,000), and Gold (AED 12,500) tier packages inclusive of VAT.
• Public Cord Blood Banking Free donation of cord blood to a public bank for use by patients in need, creating a diverse pool of stem cells supporting research and clinical trials for treatment of over 80 conditions.
• Sample Collection, Processing and Storage Establishment and operationalization of national biobanks through Build-Operate-Transfer models, ensuring biospecimen preservation with uncompromising quality including blood, tissue, and saliva with integrated health metadata.
• Global Logistics and Distribution Global cold-chain logistics delivering biospecimens worldwide, including disease-nested cohorts, transplant-grade samples, and HLA-typed samples with custom cohort design for pharma and academia.
• Research and Development Services Biomarker discovery and validation pipelines, advanced molecular assays, sequencing, genotyping, histopathology, digital pathology, and organoid and iPSC development for translational research support.
• Data and Bioinformatics Support

Quantifiable outcome

• 80+ diseases treatable with cord blood stem cells including blood cancers, immune deficiencies, genetic disorders
• +4 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Partnerships

14 partnerships are on record, tiered flagship, core and minor.

• Bascom Palmer Eye Institute (University of Miami Health System)flagshipStrategic or Co-development Partner · 2 July 2026Partnership to establish the Middle East's first Eye Bank in Abu Dhabi. Bascom Palmer, ranked America's best eye hospital 24 times by U.S. News & World Report, supports clinical protocols, training, and research. Creates sustainable ecosystem for corneal transplantation, reducing reliance on imported tissue. Collaboration with Hayat (UAE national organ donation initiative) for tissue recovery and distribution.
• BioTwinflagshipTechnology or Integration · 25 June 2026Strategic partnership to expand AI-powered Virtual Human Twin technology in UAE. Combines BioTwin's longitudinal biomarker platform with Abu Dhabi Biobank's biological, genomic, and clinical data to enable early detection, personalized prevention, and precision health. First application focuses on multi-cancer screening. Announced at BIO International Convention 2026 in San Diego.
• Human Life CORD Japan Inc.flagshipStrategic or Co-development Partner · 1 May 2026Strategic partnership to localize development and clinical application of umbilical cord-derived mesenchymal stem cell (UC-MSC) therapies in Abu Dhabi. Establishes one of UAE's first localized GMP manufacturing and clinical translation pathways for UC-MSC therapies targeting diabetes complications, musculoskeletal disorders, and age-related frailty. Supports end-to-end development from biospecimen access to clinical application.
• Mediclinic Middle EastcoreChannel Partner/ Reseller/ Distributor · 3 November 2025Partnership to expand access to public cord blood donation services at Mediclinic Airport Road Hospital and Mediclinic Al Jowhara Hospital. Families receive cord blood banking options during prenatal care with seamless collection and transfer to Abu Dhabi Biobank's Masdar City facility. Network participation tripled since May 2025.
• American Society of Regenerative Medicine (ASRM)minorGTM or Marketing Partner · 23 October 2025Partnership to convene the Regenerative Medicine Congress 2025 in Dubai. Abu Dhabi Biobank leading on biospecimen preservation, with global experts discussing cutting-edge advancements in stem cell therapy for Parkinson's Disease, Multiple Sclerosis, reverse aging, and more. Paul Downey delivered keynote on cord blood as strategic resource for regenerative medicine.
• AstraZenecaflagshipStrategic or Co-development Partner · 1 October 2025Partnership to advance precision medicine and translational research. Combines Abu Dhabi Biobank's biospecimen repository and population genomic data with AstraZeneca's expertise across cardiovascular, renal, metabolic, respiratory, immunology, and oncology therapy areas. Aims to accelerate biomarker discovery, pharmacogenomics, and patient stratification while supporting Abu Dhabi's ambition to become a global hub for biomedical research.
• NMC HealthcarecoreChannel Partner/ Reseller/ Distributor · 22 September 2025Collaboration to offer cord blood banking services at NMC hospitals across Abu Dhabi, including private storage for families and public donation options for research. Partnership launched at five NMC branches: NMC Royal Hospital Abu Dhabi, NMC Khalifa City, NMC Specialty Hospital Abu Dhabi, NMC Royal Hospital Mohammed Bin Zayed City, and NMC Specialty Hospital Al Ain. Features robotic automation for sample handling and storage.
• ProFaM (UK)minorStrategic or Co-development Partner · 1 January 2025Partnership through M42's Danat Al Emarat Hospital for Women & Children to perform ovarian tissue cryopreservation (OTC), empowering women to preserve fertility or delay menopause naturally. Announced at Arab Health 2025 as part of advanced reproductive health services expansion.
• Department of Health - Abu Dhabi (DoH)flagshipStrategic or Co-development PartnerDoH and M42 collaborated to launch Abu Dhabi Biobank as a strategic initiative and key pillar of health transformation. DoH provides regulatory oversight, enables public cord blood banking services, and oversees related operational activities. Abu Dhabi Biobank accredited to DoH standards and operates within nationally governed framework aligned with international biobanking standards.
• M42flagshipStrategic or Co-development PartnerM42, global tech-enabled health powerhouse, partnered with DoH to develop and operate Abu Dhabi Biobank. Abu Dhabi Biobank is managed and operated by G42 Laboratory LLC (an M42 affiliate). M42 provides technological infrastructure including AI capabilities, genomics expertise, and operational capabilities through its network including IROS (UAE-based CRO) for clinical research support.
• Danat Al Emarat Hospital for Women & ChildrencoreChannel Partner/ Reseller/ DistributorM42-owned specialty women's and children's hospital serving as key partner for cord blood banking services. One of initial launch partners for Abu Dhabi Biobank cord blood banking program. Located in Rabdan, Abu Dhabi.
• Corniche HospitalcoreChannel Partner/ Reseller/ DistributorMaternity hospital offering comprehensive obstetrics, gynecology, and neonatology services. Initial launch partner for Abu Dhabi Biobank cord blood banking program. Located in Al Zahiyah, Abu Dhabi.
• Kanad HospitalcoreChannel Partner/ Reseller/ DistributorTrusted healthcare focused on maternal and child health. Initial launch partner for Abu Dhabi Biobank cord blood banking program. Located in Sanaiya St, Al Ain, Abu Dhabi.
• Hayat (UAE National Organ Donation Initiative)coreStrategic or Co-development PartnerUAE's national organ donation initiative collaborating with Abu Dhabi Biobank Eye Bank on recovery, processing, preservation, and distribution of corneal tissue. Supports sustainable local supply chain from donor through to recipient.

Scale indicators9 records

Recent moves9 records

Expansion highlights7 records

Regional players

• Singapore National Biobank: Singapore's national biobank collects and characterizes biospecimens from consented Singaporean participants to support precision medicine. Regional peer with similar population-genomics and translational research mandate, but serving Southeast Asian rather than MENA populations.
• IROS (M42-affiliated CRO): IROS is a UAE-based clinical research organization operating under M42, providing clinical trial support to pharma clients. Directly comparable as an affiliated peer serving the same regional pharma customers and leveraging ADBB biospecimens for translational and clinical-trial services.

Others

• Hamilton Company: Hamilton is a leading provider of automated sample storage and liquid handling robotics used by major biobanks globally. Comparable to ADBB's robotic biobanking automation technology stack, though Hamilton operates as an equipment/infrastructure vendor rather than a direct biobank competitor.

Direct peers

• Cryo-Cell International: Cryo-Cell is a leading cord blood and menstrual stem cell banking company with private and public banking options. Comparable to ADBB as a publicly listed benchmark for unit economics in family cord blood banking.
• ViaCord: ViaCord is a private and family cord blood banking service offering collection, processing, and long-term cryopreservation of newborn stem cells. Direct comparison to ADBB's private cord blood banking tiers (Bronze/Silver/Gold) in terms of customer profile, pricing model, and service offering.
• Saudi National Biobank: Saudi Arabia's national biobank initiative collects and stores biological samples from Saudi populations for research. ADBB's GM Paul Downey consulted on this project per his background, and the two are regional peers competing for MENA population-genomics leadership.
• CBR (Cord Blood Registry): CBR is one of the largest private cord blood banking services globally, storing samples for family use. It is a direct competitor in private cord blood banking pricing, customer acquisition, and storage longevity — relevant for benchmarking ADBB's tiered offering.
• UK Biobank: UK Biobank is a population-scale biomedical resource with deep phenotypic and genomic data on 500,000+ participants. It is the most direct global comparison for ADBB given that ADBB's GM and several senior leaders came directly from UK Biobank, and both operate hybrid biobanking models serving pharma, academic, and government research clients.
• Qatar Biobank: Qatar Biobank is a national, population-scale biobank collecting biological samples and health data from Qatari and long-term resident populations. It is a direct regional peer — both serve MENA populations, are government-backed, and focus on genomic-diverse cohorts for translational research.

Broad incumbents

• Azenta Life Sciences (formerly Brooks Life Sciences): Azenta provides sample storage, biobanking services, automated cold-chain management, and genomic services globally. Comparable to ADBB's automated cryopreservation infrastructure and B2B biospecimen management offerings, though Azenta operates as a broad incumbent serving pharma/biotech with broader portfolio scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Abudhabibiobank
• Facebookfacebook.com/abudhabibiobank
• LinkedInlinkedin.com/company/abu-dhabi-biobank

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Abu Dhabi Biobank